|
US5739166A
(en)
*
|
1994-11-29 |
1998-04-14 |
G.D. Searle & Co. |
Substituted terphenyl compounds for the treatment of inflammation
|
|
US5686470A
(en)
*
|
1995-02-10 |
1997-11-11 |
Weier; Richard M. |
2, 3-substituted pyridines for the treatment of inflammation
|
|
US5596008A
(en)
*
|
1995-02-10 |
1997-01-21 |
G. D. Searle & Co. |
3,4-Diaryl substituted pyridines for the treatment of inflammation
|
|
CZ292843B6
(cs)
*
|
1996-07-18 |
2003-12-17 |
Merck Frosst Canada & Co. |
Derivát pyridinu a farmaceutický prostředek s jeho obsahem
|
|
US5861419A
(en)
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
AU729320B2
(en)
|
1996-07-31 |
2001-02-01 |
Shionogi & Co., Ltd. |
Novel para-terphenyl compounds
|
|
US6525053B1
(en)
|
1997-08-22 |
2003-02-25 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6307047B1
(en)
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6046217A
(en)
*
|
1997-09-12 |
2000-04-04 |
Merck Frosst Canada & Co. |
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
|
|
US6004950A
(en)
*
|
1997-09-12 |
1999-12-21 |
Merck Frosst Canada, Inc. |
2-aminopyridines as inhibitors of cyclooxygenase-2
|
|
US6040450A
(en)
|
1997-09-25 |
2000-03-21 |
Merck & Co., Inc. |
Process for making diaryl pyridines useful as cox-2-inhibitors
|
|
AR015938A1
(es)
|
1997-09-25 |
2001-05-30 |
Merck Sharp & Dohme |
Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
|
|
US7041694B1
(en)
|
1997-12-17 |
2006-05-09 |
Cornell Research Foundation, Inc. |
Cyclooxygenase-2 inhibition
|
|
CN1204890C
(zh)
*
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
ES2412409T3
(es)
|
1997-12-22 |
2013-07-11 |
Euro-Celtique S.A. |
Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
US7125903B1
(en)
|
1999-09-14 |
2006-10-24 |
Aventis Pharmaceuticals Inc. |
Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
|
|
US7091199B1
(en)
|
1999-09-14 |
2006-08-15 |
Aventis Pharmaceuticals Inc. |
Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
|
|
US7253165B2
(en)
*
|
1999-09-14 |
2007-08-07 |
Aventis Pharmaceuticals Inc. |
Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
|
|
DE10001166A1
(de)
|
2000-01-13 |
2001-07-19 |
Merckle Gmbh |
Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
|
|
SI1299104T1
(sl)
|
2000-02-08 |
2009-10-31 |
Euro Celtique Sa |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
|
IL151058A0
(en)
|
2000-02-08 |
2003-04-10 |
Euro Celtique Sa |
Controlled-release compositions containing opioid agonist and antagonist
|
|
PH12001001175B1
(en)
*
|
2000-05-26 |
2006-08-10 |
Merck Sharp & Dohme |
5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis
|
|
US6664256B1
(en)
|
2000-07-10 |
2003-12-16 |
Kowa Co., Ltd. |
Phenylpyridazine compounds and medicines containing the same
|
|
EP1406609B1
(en)
*
|
2000-12-21 |
2006-09-06 |
Nitromed, Inc. |
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
US20030065002A1
(en)
|
2001-05-11 |
2003-04-03 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant controlled-release opioid dosage form
|
|
AU2002316738B2
(en)
*
|
2001-07-18 |
2009-01-08 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US7914818B2
(en)
|
2001-08-06 |
2011-03-29 |
Purdue Pharma L.P. |
Opioid agonist formulations with releasable and sequestered antagonist
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
WO2003013433A2
(en)
*
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
KR100809489B1
(ko)
*
|
2001-10-10 |
2008-03-03 |
씨제이제일제당 (주) |
사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난4'-메탄설포닐-비페닐 유도체
|
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
US6797825B2
(en)
|
2001-12-13 |
2004-09-28 |
Abbott Laboratories |
Protein kinase inhibitors
|
|
US7271266B2
(en)
*
|
2002-03-28 |
2007-09-18 |
Merck & Co., Inc. |
Substituted 2,3-diphenyl pyridines
|
|
ES2320748T5
(es)
|
2002-04-05 |
2017-02-20 |
Euro-Celtique S.A. |
Matriz para la liberación sostenida, invariable e independiente de compuestos activos
|
|
AU2003261281A1
(en)
*
|
2002-07-29 |
2004-02-16 |
Nicox S.A. |
Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
|
|
EP2422773A3
(en)
*
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
|
WO2005000194A2
(en)
|
2002-10-08 |
2005-01-06 |
Rinat Neuroscience Corp. |
Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
|
|
JP4584713B2
(ja)
*
|
2002-10-08 |
2010-11-24 |
ライナット ニューロサイエンス コーポレイション |
神経成長因子アンタゴニストを投与することによって術後疼痛を処置するための方法および神経成長因子アンタゴニストを含有する組成物
|
|
GB0225548D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Compounds
|
|
WO2004041256A2
(en)
*
|
2002-11-08 |
2004-05-21 |
Novo Nordisk A/S |
Safe chemical uncouplers for the treatment of obesity
|
|
US20040102421A1
(en)
*
|
2002-11-21 |
2004-05-27 |
Children's Hospital Research Center At Oakland |
Tocopherol and tocotrienol anti-inflammatory medicaments
|
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
|
US7569364B2
(en)
*
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
|
CN101014364B
(zh)
*
|
2002-12-24 |
2012-01-18 |
里纳特神经系统学公司 |
抗ngf抗体及其使用方法
|
|
PL379983A1
(pl)
*
|
2003-02-19 |
2006-11-27 |
Rinat Neuroscience Corp. |
Sposoby leczenia bólu polegające na podaniu antagonisty czynnika wzrostu nerwów i niesteroidowego leku przeciwzapalnego oraz zawierające je kompozycje
|
|
EP2385040A1
(en)
|
2003-03-14 |
2011-11-09 |
ONO Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
|
|
MY135852A
(en)
*
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
EP1663229B1
(en)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
|
WO2005044227A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical compositions
|
|
US20050100594A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nilendu Sen |
Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
|
|
EP3372614B1
(en)
|
2004-04-07 |
2022-06-08 |
Rinat Neuroscience Corp. |
Methods for treating bone cancer pain by administering a nerve growth factor antagonist
|
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
CA2916869A1
(en)
|
2004-06-12 |
2005-12-29 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7271383B2
(en)
*
|
2004-08-11 |
2007-09-18 |
Lexmark International, Inc. |
Scanning system with feedback for a MEMS oscillating scanner
|
|
WO2006030925A1
(ja)
|
2004-09-13 |
2006-03-23 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
GB0611907D0
(en)
*
|
2006-06-15 |
2006-07-26 |
Glaxo Group Ltd |
Compounds
|
|
EP1702558A1
(en)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
US8536182B2
(en)
*
|
2005-07-26 |
2013-09-17 |
Glaxo Group Limited |
Benzylpiperazine derivatives and their medical use
|
|
US8003642B2
(en)
|
2006-03-10 |
2011-08-23 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
|
ES2636657T3
(es)
*
|
2006-06-19 |
2017-10-06 |
Alpharma Pharmaceuticals Llc |
Composición farmacéutica
|
|
KR20090031688A
(ko)
*
|
2006-06-28 |
2009-03-27 |
글락소 그룹 리미티드 |
Ｇｐｒ３８ 수용체 매개 질환의 치료에 유용한 피페라지닐 유도체
|
|
CN103450077B
(zh)
*
|
2007-06-08 |
2016-07-06 |
满康德股份有限公司 |
IRE-1α抑制剂
|
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
WO2009088673A2
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
MY150600A
(en)
*
|
2008-07-07 |
2014-01-30 |
Euro Celtique Sa |
Use of opioid antagonists for treating urinary retention
|
|
US20100160351A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
|
WO2010071865A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
|
DK2479166T3
(da)
|
2009-02-27 |
2014-09-01 |
Cadila Healthcare Ltd |
Fremgangsmåde til fremstilling af etoricoxib
|
|
UY32487A
(es)
|
2009-03-10 |
2010-06-30 |
Euro Celtique Sa |
Composiciones farmacéuticas de liberación inmediata comprendiendo oxicodona y naloxona
|
|
WO2011032175A1
(en)
|
2009-09-14 |
2011-03-17 |
Nuon Therapeutics, Inc. |
Combination formulations of tranilast and allopurinol and methods related thereto
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
CA2808577C
(en)
|
2010-08-19 |
2018-09-25 |
Abbott Laboratories |
Anti-ngf antibodies and their use
|
|
KR101572336B1
(ko)
|
2010-12-22 |
2015-11-26 |
퍼듀 퍼머 엘피 |
케이싱된 탬퍼 저항성 제어 방출 투여 형태
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
JP5889029B2
(ja)
*
|
2011-02-14 |
2016-03-22 |
旭化成イーマテリアルズ株式会社 |
ハロゲン原子を有する多環式芳香族化合物の製造方法
|
|
US9745373B2
(en)
|
2011-05-20 |
2017-08-29 |
Alderbio Holdings Llc |
Anti-CGRP compositions and use thereof
|
|
WO2013105106A1
(en)
|
2011-11-03 |
2013-07-18 |
Cadila Healthcare Limited |
An improved process for the preparation of etoricoxib and polymorphs thereof
|
|
AU2013271564A1
(en)
|
2012-06-06 |
2014-12-04 |
Zoetis Services Llc |
Caninized anti-NGF antibodies and methods thereof
|
|
PL2887924T3
(pl)
|
2012-08-27 |
2017-09-29 |
Cadila Healthcare Limited |
Kompozycje farmaceutyczne etorykoksybu
|
|
WO2014123899A1
(en)
|
2013-02-05 |
2014-08-14 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
UA116567C2
(uk)
|
2013-07-23 |
2018-04-10 |
Євро-Селтік С.А. |
Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
|
|
JP2019515671A
(ja)
|
2016-04-15 |
2019-06-13 |
アルダー バイオファーマシューティカルズ、インコーポレイテッド |
抗ｐａｃａｐ抗体及びそれらの使用
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
JP7065951B2
(ja)
|
2017-09-22 |
2022-05-12 |
ジュビラント エピパッド エルエルシー |
Ｐａｄ阻害剤としての複素環式化合物
|
|
WO2019077631A1
(en)
|
2017-10-18 |
2019-04-25 |
Jubilant Biosys Limited |
IMIDAZO-PYRIDINE COMPOUNDS FOR USE AS PAD INHIBITORS
|
|
EP3707135A1
(en)
|
2017-11-06 |
2020-09-16 |
Jubilant Prodel LLC |
Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation
|
|
IL274762B2
(en)
|
2017-11-24 |
2023-10-01 |
Jubilant Episcribe Llc |
Novel heterocyclic compounds as prmt5 inhibitors
|
|
CA3093772C
(en)
|
2018-03-12 |
2024-04-16 |
Zoetis Services Llc |
Anti-ngf antibodies and methods thereof
|
|
WO2019175897A1
(en)
|
2018-03-13 |
2019-09-19 |
Jubilant Biosys Limited |
Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
|
|
CA3229059A1
(en)
|
2021-08-27 |
2023-03-02 |
H. Lundbeck A/S |
Treatment of cluster headache using anti-cgrp antibodies
|
|
WO2024067463A1
(zh)
*
|
2022-09-27 |
2024-04-04 |
苏州阿尔脉生物科技有限公司 |
苯并[7]环烯类衍生物、包含其的药物组合物及其医药用途
|